Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
The Bcl-2 specific BH3 mimetic ABT-199: a promising targeted therapy for t(11;14) multiple myeloma. [electronic resource] by
- Touzeau, C
- Dousset, C
- Le Gouill, S
- Sampath, D
- Leverson, J D
- Souers, A J
- Maïga, S
- Béné, M C
- Moreau, P
- Pellat-Deceunynck, C
- Amiot, M
Producer: 20140306
In:
Leukemia vol. 28
Availability: No items available.
|
|
10.
|
Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax). [electronic resource] by
- Leverson, J D
- Zhang, H
- Chen, J
- Tahir, S K
- Phillips, D C
- Xue, J
- Nimmer, P
- Jin, S
- Smith, M
- Xiao, Y
- Kovar, P
- Tanaka, A
- Bruncko, M
- Sheppard, G S
- Wang, L
- Gierke, S
- Kategaya, L
- Anderson, D J
- Wong, C
- Eastham-Anderson, J
- Ludlam, M J C
- Sampath, D
- Fairbrother, W J
- Wertz, I
- Rosenberg, S H
- Tse, C
- Elmore, S W
- Souers, A J
Producer: 20150915
In:
Cell death & disease vol. 6
Availability: No items available.
|